TNFRSF4 and aneurysmal bone cyst: In the present work we aimed to analyze circulating MDSCs, Tregs and activated (OX40+) and inhibited (PD-1+) T lymphocyte cells from ABC patients treated with 1st line treatment for advanced disease and comparing the immune profile evolution with two groups of response, clinical benefit (CB) versus progression of disease (PD).